Comparison of diagnostic value of the SARC-F and its two modified versions (SARCF-EBM and SARCF-calF) in older adults in Turkey
Geriatric Nursing, cilt.65, 2025 (SCI-Expanded, SSCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 65
- Basım Tarihi: 2025
- Doi Numarası: 10.1016/j.gerinurse.2025.103572
- Dergi Adı: Geriatric Nursing
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, AgeLine, CINAHL, MEDLINE
- Anahtar Kelimeler: Sarcopenia, SARC-F, SARC-F EBM, SARC-CalF, Diagnostic accuracy, Older adults, Turkey
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objectives: This study aimed to assess the diagnostic value of the SARC-F and its two modified versions, SARC-F EBM and SARC[sbnd]CalF. Material and Methods: This prospective observational study included 468 participants aged ≥ 65 years. The diagnostic tools assessed were the SARC-F, SARC-F EBM, and SARC[sbnd]CalF. Data on muscle strength, mass, and function were collected. Results: For BMI-based sarcopenia, SARC-F EBM demonstrated the highest sensitivity (40.0%, 95% CI: 31–49.5) and specificity (80.7%, 95% CI: 76.4–84.6), with an AUC of 0.674 (95% CI: 0.617–0.732, p < 0.001). SARC[sbnd]CalF had a lower sensitivity (17.1%, 95% CI: 10.8–25.1) but a higher specificity (87.1%, 95% CI: 83.3–90.2) and an AUC of 0.574 (95% CI: 0.512–0.636, p < 0.001). Conclusion: The SARC-F EBM demonstrated superior sensitivity and diagnostic accuracy compared to the original SARC-F and SARC[sbnd]CalF for detecting sarcopenia in older adults. SARC-F EBM may be preferred in clinical settings due to its higher sensitivity.